Growth Metrics

Opus Genetics (IRD) Depreciation & Amortization (CF) (2020 - 2026)

Opus Genetics has reported Depreciation & Amortization (CF) over the past 12 years, most recently at $13000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% to $13000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53000.0 through Mar 2026, up 130.43% year-over-year, with the annual reading at $53000.0 for FY2025, 430.0% up from the prior year.
  • Depreciation & Amortization (CF) was $13000.0 for Q1 2026 at Opus Genetics, roughly flat from $13000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $14000.0 in Q2 2025 and troughed at $1000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $2000.0 (2022), against an average of $6142.9.
  • Year-over-year, Depreciation & Amortization (CF) changed 0.0% in 2022 and then surged 233.33% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1000.0 in 2022, then skyrocketed by 200.0% to $3000.0 in 2023, then surged by 233.33% to $10000.0 in 2024, then grew by 30.0% to $13000.0 in 2025, then changed by 0.0% to $13000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Depreciation & Amortization (CF) are $13000.0 (Q1 2026), $13000.0 (Q4 2025), and $13000.0 (Q3 2025).